Company overview
Basic information
Company name
Bioliuks, UAB
Company code
186161183
Registered address
Vilniaus r. sav., Sudervės sen., Rastinėnų k.
Registration date
1994-08-03
Company age: 32 y. 2 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Wholesale of grain, unmanufactured tobacco, seeds and animal feeds
Ownership form
Private without foreign capital
UAB "Bioliuks"
Company code: 186161183
Address: Vilniaus r. sav., Sudervės sen., Rastinėnų k.
Description
This description was generated by artificial intelligence.
Bioliuks, UAB (company code 186161183) is an operational private limited liability company registered in 1994. It is a micro-sized private enterprise in the national private non-financial companies sector, with a CEO-only governance structure and private ownership. The company is based in Rastinenu k., Suderves sen., Vilniaus r. sav., Vilniaus county. Its authorised capital is EUR 2.9K, and the ownership structure indicates that more than 50% of the capital belongs to Lithuanian natural and legal persons, with no foreign investor capital. The company’s main activity is wholesale of grain, unmanufactured tobacco, seeds and animal feeds (EVRK code G.46.21.00).
In 2024, Bioliuks generated revenue of EUR 31.0K and recorded a net loss of EUR 102.6K. This resulted in a negative profitability profile, with the loss substantially exceeding annual revenue. At the balance-sheet level, the company reported equity of EUR 120.0K, liabilities of EUR 206.3K and total assets of EUR 21.3K. For 2025, the available financial indicators show a debt-to-equity ratio of 1.72, while the equity ratio was notably high relative to the company’s asset base. No employee or wage figures are provided in the available data.
In 2024, Bioliuks generated revenue of EUR 31.0K and recorded a net loss of EUR 102.6K. This resulted in a negative profitability profile, with the loss substantially exceeding annual revenue. At the balance-sheet level, the company reported equity of EUR 120.0K, liabilities of EUR 206.3K and total assets of EUR 21.3K. For 2025, the available financial indicators show a debt-to-equity ratio of 1.72, while the equity ratio was notably high relative to the company’s asset base. No employee or wage figures are provided in the available data.
Download a detailed company report
Make confident decisions with all the information about Bioliuks, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.